作者 | JR Research编译 | 华尔街大事件总部位于丹麦的诺和诺德公司长期以来在减肥药领域的领先地位是否最终会走到尽头?尽管其主要竞争对手礼来公司(NYSE:LLY)在过去两年的大部分时间里都在不断创新,试图追赶诺和诺德的主导地位,但仍不足以超越这家丹麦生物制药公司。尽管毫无疑问这两家公司仍有望在庞大的减肥药物市场中占据主导地位,但竞争对手正在投入资金并试图削弱这些优势,无论是通过内部...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.